Balancing behavior and the microbiome: Meet Els van der Goot

20180929_153534(1)

Els van der Goot, PhD student from the University of Groningen in the Netherlands, is building
connections, bridging the gaps in knowledge between behavior, biology and the microbiome.
Her passion for neurobiology and how behavior is influenced by the microbiome has made
some intriguing findings in mice with metabolic and neurologic disorders.

How did you first get interested in science and microbiome research?

I took a year off after high school to figure out which direction I wanted to continue my education
in. During that year, I came across the website for the bachelor of Life Science and Technology
at the University of Groningen (UoG), which triggered my attention with phrases like “Did you
always want to know how cancer develops?” and “Do you want to use your knowledge to
improve people’s quality of life?” I always liked puzzles, so I decided to attend the “Student for a
Day” program which meant we were given a lecture and shown some behavioral research
practicals, after which I decided that’s what I wanted to become: a biologist. After my studies, I
was allowed to work with Professor Dr. E. A. van der Zee, with whom I worked on behavioral
and cognitive deficits in mice with the metabolic disorder phenylketonuria (PKU). During this
time, we discovered the potential of the microbiome to influence behavior and under the
supervision of Professor Dr. E.A. van der Zee and Professor Dr. J. Falcao-Salles, I wrote a
project proposal for the Adaptive Life program and received a PhD-bursary position.

Can you give a summary of your current project?

My project tries to unravel the link between the microbiota, brain and behavior in mice with PKU.
PKU is caused by a deficiency in the hepatic enzyme that converts the essential amino acid
phenylalanine (Phe) into tyrosine, leading to high levels of Phe in the blood and brain which,
when untreated, leads to severe intellectual disability, motor performance, anxiety, depression
disorders and epilepsy. The current treatment is a strict Phe-restricted, protein-free diet with
amino acid supplementation, which can prevent the most severe symptoms, although research
shows that the gain of the diet remains suboptimal for the patients. Additionally, alterations of
gut microbiota are likely to occur in response to this metabolic disorder since the treatment
consists of drastic changes in dietary intake and diet and environment are known to affect the
microbiome. The microbiota itself has been implicated in the evolution of social behavior and
developmental programming of the brain, affecting social and cognitive behaviors. A paper in
2011 demonstrated that strain-specific behavioral profiles could be transplanted by
interchanging the microbiota between strains. For us, this was a potential game changer as we
have been working with PKU mice, in which we also found the behavioral phenotype to be
different between strains regardless of having an identical mutation responsible for PKU.
Therefore, we now aim to study the impact of the microbiome in PKU mice and how it affects
their behavior and ability to master learning tasks.

In addition, by manipulating the gut microbiota we will be able to understand in more detail the
evolutionary developments between the microbiome and brain functioning: has (part of) the gut
microbiota adapted to the PKU environment? How can we employ alterations of the gut
microbiota to influence behavior, with emphasis on improving cognition and anxiety/fear in a
PKU environment? From an evolutionary perspective, the Phe-restricted diet taken by PKU
patients selects against bacterial species capable of degrading Phe. By increasing Phe diet
contents in our experiments we will increase the selection pressure towards this type of
microbes, which can be used as probiotics.

20180926_150129(1)

What will be a typical day for you in the lab?

Every day is quite different from the other! During experiments I spent most my time in the
animal facility, being busy with breeding, cleaning, feeding and doing behavioral tests with my
mice. Next to that, I often supervise masters and undergraduate students, and divide my time
between analyzing the (behavioral) results and lab work, which generally involves DNA
extractions for genotyping and microbiome sequencing and immunohistological staining for
brain markers for learning and memory. Lastly, I attend weekly lab meeting for both the
molecular neurobiology and microbial ecology group to discuss important issues and share
results and ideas.

What do you find most interesting about your project? What is the most interesting or
surprising result you have found?

I was really excited when I first read the paper in which they exchanged the microbiome in two
strains of mice and with that, exchanged their strain-specific behavior! Therefore, the most
interesting part about the project would be being able to replicate and expand this in our PKU
mice – exchanging the microbiota of our “diseased” mice with our non-diseased control mice – and see whether the behavior is (partially) caused by changes in their microbiome (our earlier
studies revealed a dramatic difference in microbiome between the PKU and non-PKU mice
within a nest) as a result of their metabolism and diet. As we have just started the project, we
unfortunately do not have results on the behavior, but are in the process of analyzing our first
data.

What kind of microbiome research do you perform and how does it impact health and
disease or the environment? Where do you see this heading in the next five years?

In the end, we want to manipulate the microbiome and try to develop knowledge and insights to
be used in the field of “evolutionary medicine” that can improve social and mental health in
these mice. This principle could then be translated to human applications and perhaps even
other (metabolic) diseases and general health. It is a growing field and I think that in the next
five years we will have significantly increased our understanding of the symbiosis between hosts
and their microbiome and we probably will have learned that we are more dependent on our
microbes than we could have thought.

What are your hobbies?

I played volleyball when I was younger, but during my master internships, I decided it took too
much time. I started again two years ago and this year we even signed up for a recreational
competition. Next to that, I love to play video- and board games, especially when it involves
strategy games or general role-playing games.

What are the major challenges you face in your research with regards to sample
collection, nucleic acid isolation and data analysis?

I think the biggest challenge for me is that I’m trained as a neurobiologist and have to learn a
whole new expertise while being one of the first PhD-students in our university to form a bridge
between the molecular neurobiology department and the microbial ecology group.

Concerning the data analysis, I’m currently being trained in bioinformatics for my first
microbiome analysis, which is challenging per se, but it will also be quite challenging to interpret
the complex data correctly. However, I’m excited to see the first results and learn new things.

Which MO BIO or QIAGEN products do you use/have you used in the past and what did
you like about the products?

I have made use of the QIAGEN extraction kits for both genotyping of my mice with qPCR and
DNA extractions from fecal samples for my microbiome analysis (QIAamp PowerFecal Pro DNA
Kit, DNeasy PowerSoil Pro Kit, DNeasy 96 PowerSoil Pro QIAcube HT Kit). I like these kits as
they are easy to use and produce quality DNA extractions.

————–

To try out our DNeasy PowerSoil Pro Kit, request a quote for a trial kit

To try out our QIAamp PowerFecal Pro DNA Kit, request a quote for a trial kit

Heather Martinez

Associate Director, Global Strategic Marketing, Microbiome

Heather Martinez received her PhD in Biomedical Sciences from the University of California, San Diego in 2007 and has a scientific background in subjects including microbiome research, molecular biology, cell biology and protein biochemistry. She was Associate Director of Marketing at MO BIO Laboratories, Inc. which was acquired by QIAGEN in 2015. Currently, Dr. Martinez is responsible for strategic marketing for QIAGEN’s microbiome portfolio.

Your email address will not be published. Required fields are marked *